English
Polski
Español
українська
Criteria for identifying GCA in different clinical situations
Can the available criteria for giant cell arteritis (GCA) be used to identify GCA in all clinical situations? What should we focus on?
2017-11-21
Can the available criteria for giant cell arteritis (GCA) be used to identify GCA in all clinical situations? What should we focus on?
What is the currently recommended treatment for gout attacks?
What is the current approach to treatment of giant cell arteritis?
Has evidence-based medicine been able to prove beneficial or harmful effects of any particular diets in patients with gout?
In which patients with polymyalgia rheumatica should we suspect giant cell arteritis?
Dr Filip Van den Bosch, associate professor of rheumatology at Ghent University, Belgium, reviews the current diagnostic methods, treatment, and activity measurement used in patients with nonradiographic axial spondyloarthritis in a conversation with Dr Mariusz Korkosz.
What in your opinion is most important in the diagnostics of gout? Which of the available diagnostic criteria seem most useful?
What are the typical features of giant cell arteritis (GCA)? What are the atypical features of GCA and in what proportion of patients can they be seen?
Which patients with polymyalgia rheumatica require treatment with methotrexate and leflunomide?
